{
    "2018-06-19": [
        [
            {
                "time": "2018-09-10",
                "original_text": "What’s the Latest on Teva’s Fremanezumab?",
                "features": {
                    "keywords": [
                        "Teva",
                        "Fremanezumab",
                        "latest"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "The Charts and Indicators on Johnson & Johnson Are Still Mostly Bearish",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "charts",
                        "indicators",
                        "bearish"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "Opioid Ruling Could Send Purdue, Drugmakers to Court",
                "features": {
                    "keywords": [
                        "opioid",
                        "ruling",
                        "Purdue",
                        "drugmakers",
                        "court"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "ITOT, JPM, XOM, JNJ: Large Inflows Detected at ETF",
                "features": {
                    "keywords": [
                        "ITOT",
                        "JPM",
                        "XOM",
                        "JNJ",
                        "ETF",
                        "inflows"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "energy",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "investor",
                        "conference",
                        "second-quarter",
                        "results"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "3 Stocks That Are Absurdly Cheap Right Now",
                "features": {
                    "keywords": [
                        "stocks",
                        "cheap"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "FOCUS-After split from Actelion, Idorsia CEO plans to raise more cash in 2019",
                "features": {
                    "keywords": [
                        "split",
                        "Actelion",
                        "Idorsia",
                        "CEO",
                        "cash",
                        "2019"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "Alliance Pharma To Buy Rights To J&J's Nizoral In APAC For Â£60 Mln; Stock Up",
                "features": {
                    "keywords": [
                        "Alliance Pharma",
                        "J&J",
                        "Nizoral",
                        "APAC",
                        "stock up"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "CSBR Up 36% This Month, ZIOP Hit By Clinical Hold, Watch Out For SRPT Today",
                "features": {
                    "keywords": [
                        "CSBR",
                        "ZIOP",
                        "SRPT",
                        "clinical hold",
                        "up"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            }
        ]
    ]
}